Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

PPID quality of life tool to be developed
Pituitary Pars Intermedia Dysfunction can cause laminitis.
RVC to undertake three-year project.

Researchers from the Royal Veterinary College (RVC) have announced a project to develop a new tool to assess the quality of life of horses and ponies with Pituitary Pars Intermedia Dysfunction (PPID).

A hormone disorder that affects the pituitary gland of horses, PPID often causes the animals to develop laminitis, leading to extreme pain, instability of the pedal bone within the hoof capsule and in some cases, euthanasia. 

As well as these, PPID can also cause weight loss, behavioural changes and lethargy. 

Owing to the potential negative impact of PPID symptoms on an equine's quality of life, researchers are will develop an assessment tool to assist veterinary professionals and equine owners in making informed decisions about care.

Professor Nicola Menzies-Gow, of the RVC, said: “This is an exciting project that will hopefully allow development of a tool that can be used to objectively assess the quality of life of horses and ponies with PPID and determine which aspects of the disease and its treatment have the greatest impact on this.”

Set to be developed over the course of three years, the tool will be created first by interviewing equine veterinary surgeons and owners of equines with PPID to ascertain which aspects of the disorder appear to impact quality of life the most.

The data and information gathered from this will be used to develop a questionnaire for a larger number of horse owners, and following this, the question-based tool will be created.

For the remaining two years of the study, the tool will be used to assess 140 horses and ponies newly diagnosed with PPID. These equines will be followed over the two-year period to see how quality of life is impacted, and whether the drug pergolide improves this. 

Ultimately, the study aims to determine the effect of pergolide on the quality of life of equines diagnosed with PPID, and to assist veterinary professionals and owners in decision-making regarding treatments or euthanasia. 

The research will be led by Nicola Menzies-Gow, Professor of Equine Medicine at the RVC, Christine Nicol, Professor of Animal Welfare at the RVC, Dr Edd Knowles and Dr Imogen Schofield from CVS.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.